Navigation Links
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
Date:7/8/2009

. "Then, in March 2008, we performed the first enlargement of the path blood follows as it exits the heart using the CorMatrix ECM, in lieu of a prosthetic device, for a patient undergoing valve surgery.

The first mitral valve reconstruction using CorMatrix occurred at St. Francis Heart Center as well, in October of 2008. Large defects had been created in a patient's valve by infection. The valve was restored to normal function using CorMatrix patches, avoiding a valve replacement.

"We have been able to make similar repairs for other patients since," added Gerdisch.

The CorMatrix ECM is derived from porcine small intestines and is processed in a way that removes all cells, leaving the complex structural matrix intact. Once surgically implanted, it serves as a scaffold, allowing the patient's cells to infiltrate and ultimately replace the ECM scaffold.

While the patient continues to heal, the matrix gradually is replaced as the body reinforces and remodels the tissue. In the past, tissue replacement has been limited by options for implantation.

Animal tissue implants are subject to calcium deposition and hardening, due to the body's ability to recognize them as foreign. Synthetic material lacks the performance characteristics of tissue and causes an inflammatory response. ECM, however, leads to growth of functional tissue where scarring would normally be expected.

More information about how the ECM is being used at St. Francis Hospital & Health Centers is at www.cardiactissuerepair.net.

About St. Francis Heart Center

Referring physicians wanting to learn more about heart valve surgery and Dr. Marc Gerdisch's work with ECM can call toll-free at 1-866-237-0565. The St. Francis Heart Center is dedicated to providing our patients with the region'
'/>"/>

SOURCE St. Francis Heart Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
2. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
3. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
6. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
7. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
8. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
9. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
10. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
11. Surgeon Generals Call to Action to Prevent DVT/PE Praised by NATT as Turning Point

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...swire/ -- Althea Technologies, Inc., a leading pro...r biopharmaceutical products announced the additio...pany,s platform of services, which will be oversee...tor of Formulation Development. This investment in... scientists, along with new laboratory facilities ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 1RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 1Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 2Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 4
...l Therapeutics (CTI),(Nasdaq and MTA: CTIC) announ...nd Drug Administration (FDA), CTI expects to begin...) and request priority review for pixantrone to tr...L) in the first quarter of 2009.,If granted priori... the end of,2009. , "This communication from t...
...t Angiolix has similar efficacy to Avastin alone a...th potentially less side-effects; study validates ...DALLAS, Jan. 26 ACCESS PHARMACEUTICALS, INC. (OTC...k on its proprietary humanized monoclonal antibody... with high affinity to the its target, lactadherin...
Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
(Date:11/8/2009)...jury of 8 people in the Western District of Pennsy...pain and suffering for a medical malpractice case....ia Nocera of Thomas E. Crenney and Associates, LLC... Monestersky and against the Uniontown Hospital. ... hysterectomy at age 18. , ...
(Date:11/8/2009)...Newswire-USNewswire/ -- Pharmaceutical Research an...sident Ken Johnson released the following statemen..., "We are disappointed, but not surprised by toda...rdworking Americans as well as nearly half of the ...oted against the bill. ,, "While well intention...
(Date:11/8/2009)...ssage of Health Care Reform Bill ,, Critical ...erage for all Americans ,, BALTIMORE, Nov. 7 /...nited States House of Representatives passed criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,, T...
(Date:11/7/2009)...swire-USNewswire/ -- The American Medical Associat...f Health at the Family Violence Prevention Fund, w...t its semi-annual policy-making meeting. The Cita...r the AMA House of Delegates bestows on a non-phys...i-bin/prnh/20081209/AMALOGO ) ,, "Ms. James h...
(Date:11/7/2009)...holics have a responsibility to vigorously oppose ...uo." ,, WASHINGTON, Nov. 7 /PRNewswire-USNe...rown released the following statement on the news ...ancy Pelosi,s Affordable Health Care for America A...he status quo for abortion is voted upon. ,, "...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
... prescribed to lower cholesterol, may have protect...inic cohort study looked at three different aspect...tile dysfunction and prostate enlargement. Initial...al audio and video resources, including excerpts f...
...that outcomes of robotic assisted kidney cancer su...igh volume centers, prove more beneficial to patie...hored by Fox Chase robotic surgeon Rosalia Viterbo...ve the entire or a portion of the kidney. This is ...
...rts to cut back, , , SATURDAY, April 25 (H... the most important lifestyle changes people with ... the recommendation, a new study has found. , Res...e with heart failure is 2,000 milligrams, particip...
...astic Surgery increased too, with breast implants ..., bigger bank balances and stunning senior celebs ... April 25 A NEW trend in beauty has been seen by ...ving non-surgical treatments including Botox, derm...
...nsurance coverage affect their access to quality c...Cancer Center, insurance coverage may not only aff...e quality of care they receive. Research findings,...scovered a discrepancy in the type of surgical tre...
...tiple doctors who write prescriptions for drugs to...more on the importance of making sure that every d...sten to this report from Prescription Solutions at...xt, graphics and photos for free and unrestricted ...
Other Medicine News:Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 2Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 3Health News:Major statin study reveals several important findings for reducing prostate cancer and disease 4Health News:Robotic assisted kidney cancer surgery proves to be beneficial to patients 2Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:Does a person's insurance coverage affect their access to quality cancer care? 2
BUN (Urea Nitrogen)
Bilirubin Direct Reagent
...e is the first microplate spectrophotometer design...week. With rugged hardware, proven optical perform...arrier of traditional spectrophotometry to obtain ...rument can easily read up to eight, 1 cm Biocell c...
LS 45 Luminescence Spectrometer, 120V
Medicine Products: